PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97339140 |
Filing Date: 03/30/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97339140 |
---|---|
MARK INFORMATION | |
*MARK | OPTUM EVIDENCE ENGINE |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | OPTUM EVIDENCE ENGINE |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | OPTUM, INC. |
*MAILING ADDRESS | 9900 BREN ROAD EAST, MN008-T202 |
*CITY | MINNETONKA |
*STATE (Required for U.S. applicants) |
Minnesota |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
55343 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Research and development services in the field of healthcare; Medical and scientific research in the field of genomics; clinical research in the field of health care, genomics, and medicine; clinical and medical research, data collection and scientific analysis and communication of results to the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 01/10/2022 |
FIRST USE IN COMMERCE DATE | At least as early as 01/10/2022 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-50237398-20220330173 052614738_._Optum_Evidenc e_Engine_for_Clinical_Gen omics_Research___Optum.pdf |
CONVERTED PDF FILE(S) (5 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\391\97339140\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\391\97339140\xml1\ APP0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\391\97339140\xml1\ APP0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\391\97339140\xml1\ APP0006.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\391\97339140\xml1\ APP0007.JPG | |
SPECIMEN DESCRIPTION | printout of webpage displaying the mark and containing advertisements for the services. |
WEBPAGE URL | http://www.optum.com/business/resources/library/evidence-engine.html?v=optum.com/evidence-engine |
WEBPAGE DATE OF ACCESS | 03/30/2022 |
ATTORNEY INFORMATION | |
NAME | Joseph V. Myers III |
ATTORNEY DOCKET NUMBER | 023845-9051 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Seyfarth Shaw LLP |
STREET | 1075 Peachtree St. NE, Suite 2500 |
CITY | Atlanta |
STATE | Georgia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 30309 |
PHONE | 404-885-6743 |
FAX | 404-892-7056 |
EMAIL ADDRESS | tmatlanta@seyfarth.com |
OTHER APPOINTED ATTORNEY | Julia K. Sutherland, Lauren M. Gregory, Stephen D. Lott, Amy A. Abeloff, Alisha H. Huls |
CORRESPONDENCE INFORMATION | |
NAME | Joseph V. Myers III |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | tmatlanta@seyfarth.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | uhgtrademarks@seyfarth.com; ipdocketatlanta@seyfarth.com; aabeloff@seyfarth.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Julia K. Sutherland/ |
SIGNATORY'S NAME | Julia K. Sutherland |
SIGNATORY'S POSITION | Attorney of Record, Illinois Bar Member |
SIGNATORY'S PHONE NUMBER | 312-460-5577 |
DATE SIGNED | 03/30/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97339140 |
Filing Date: 03/30/2022 |
The applicant's current Correspondence Information: |
Joseph V. Myers III |
PRIMARY EMAIL FOR CORRESPONDENCE: tmatlanta@seyfarth.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): uhgtrademarks@seyfarth.com; ipdocketatlanta@seyfarth.com; aabeloff@seyfarth.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|